Dexcom Inc (DXCM) kicked off at the price of $86.83: Venture capitalists have an exciting new opportunity

On Friday, Dexcom Inc (NASDAQ: DXCM) was -0.90% drop from the session before settling in for the closing price of $87.62. A 52-week range for DXCM has been $62.34 – $142.00.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 25.24%. When this article was written, the company’s average yearly earnings per share was at 11.04%. With a float of $385.58 million, this company’s outstanding shares have now reached $390.60 million.

Considering the fact that the conglomerate employs 9600 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 61.68%, operating margin of 15.88%, and the pretax margin is 18.81%.

Dexcom Inc (DXCM) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dexcom Inc stocks. The insider ownership of Dexcom Inc is 1.28%, while institutional ownership is 93.53%. The most recent insider transaction that took place on Jan 29 ’25, was worth 181,650. In this transaction EVP, Chief Financal Officer of this company sold 2,090 shares at a rate of $86.91, taking the stock ownership to the 83,526 shares. Before that another transaction happened on Jan 29 ’25, when Company’s EVP, Strategy & Corporate Dev sold 1,183 for $86.91, making the entire transaction worth $102,820. This insider now owns 42,044 shares in total.

Dexcom Inc (DXCM) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.38 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 11.04% per share during the next fiscal year.

Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators

You can see what Dexcom Inc (DXCM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.58. Likewise, its price to free cash flow for the trailing twelve months is 63.39.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.67, a number that is poised to hit 0.50 in the next quarter and is forecasted to reach 2.02 in one year’s time.

Technical Analysis of Dexcom Inc (DXCM)

Compared to the last year’s volume of 3.59 million, its volume of 2.75 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 53.39%. Additionally, its Average True Range was 2.57.

During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 88.88%, which indicates a significant increase from 82.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.19% in the past 14 days, which was lower than the 31.60% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $80.23, while its 200-day Moving Average is $90.57. Nevertheless, the first resistance level for the watch stands at $87.88 in the near term. At $88.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $89.58. If the price goes on to break the first support level at $86.18, it is likely to go to the next support level at $85.54. Now, if the price goes above the second support level, the third support stands at $84.48.

Dexcom Inc (NASDAQ: DXCM) Key Stats

There are 390,595K outstanding shares of the company, which has a market capitalization of 33.92 billion. As of now, sales total 3,622 M while income totals 541,500 K. Its latest quarter income was 994,200 K while its last quarter net income were 134,600 K.